456 related articles for article (PubMed ID: 23578028)
1. Molecular modeling and ligand docking for solute carrier (SLC) transporters.
Schlessinger A; Khuri N; Giacomini KM; Sali A
Curr Top Med Chem; 2013; 13(7):843-56. PubMed ID: 23578028
[TBL] [Abstract][Full Text] [Related]
2. SLC Transporters: Structure, Function, and Drug Discovery.
Colas C; Ung PM; Schlessinger A
Medchemcomm; 2016 Jun; 7(6):1069-1081. PubMed ID: 27672436
[TBL] [Abstract][Full Text] [Related]
3. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.
Schlessinger A; Zatorski N; Hutchinson K; Colas C
Trends Biochem Sci; 2023 Sep; 48(9):801-814. PubMed ID: 37355450
[TBL] [Abstract][Full Text] [Related]
4. Potentiating SLC transporter activity: Emerging drug discovery opportunities.
Rives ML; Javitch JA; Wickenden AD
Biochem Pharmacol; 2017 Jul; 135():1-11. PubMed ID: 28214518
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in ligands and chemical probes targeting solute carrier transporters.
Casiraghi A; Bensimon A; Superti-Furga G
Curr Opin Chem Biol; 2021 Jun; 62():53-63. PubMed ID: 33689964
[TBL] [Abstract][Full Text] [Related]
6. eUnaG: a new ligand-inducible fluorescent reporter to detect drug transporter activity in live cells.
Yeh JT; Nam K; Yeh JT; Perrimon N
Sci Rep; 2017 Feb; 7():41619. PubMed ID: 28176814
[TBL] [Abstract][Full Text] [Related]
7. Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach.
Liu HC; Goldenberg A; Chen Y; Lun C; Wu W; Bush KT; Balac N; Rodriguez P; Abagyan R; Nigam SK
J Pharmacol Exp Ther; 2016 Oct; 359(1):215-29. PubMed ID: 27488918
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
Clémençon B; Lüscher BP; Hediger MA
J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
[TBL] [Abstract][Full Text] [Related]
9. Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective.
Schlessinger A; Welch MA; van Vlijmen H; Korzekwa K; Swaan PW; Matsson P
Clin Pharmacol Ther; 2018 Nov; 104(5):818-835. PubMed ID: 29981151
[TBL] [Abstract][Full Text] [Related]
10. SLC transporters as therapeutic targets: emerging opportunities.
Lin L; Yee SW; Kim RB; Giacomini KM
Nat Rev Drug Discov; 2015 Aug; 14(8):543-60. PubMed ID: 26111766
[TBL] [Abstract][Full Text] [Related]
11. The ABCs of membrane transporters in health and disease (SLC series): introduction.
Hediger MA; Clémençon B; Burrier RE; Bruford EA
Mol Aspects Med; 2013; 34(2-3):95-107. PubMed ID: 23506860
[TBL] [Abstract][Full Text] [Related]
12. Advances and Challenges in Rational Drug Design for SLCs.
Garibsingh RA; Schlessinger A
Trends Pharmacol Sci; 2019 Oct; 40(10):790-800. PubMed ID: 31519459
[TBL] [Abstract][Full Text] [Related]
13. Structural biology of solute carrier (SLC) membrane transport proteins.
Bai X; Moraes TF; Reithmeier RAF
Mol Membr Biol; 2017; 34(1-2):1-32. PubMed ID: 29651895
[TBL] [Abstract][Full Text] [Related]
14. Computational models for predicting interactions with membrane transporters.
Xu Y; Shen Q; Liu X; Lu J; Li S; Luo C; Gong L; Luo X; Zheng M; Jiang H
Curr Med Chem; 2013; 20(16):2118-36. PubMed ID: 23409721
[TBL] [Abstract][Full Text] [Related]
15. Transporter-Mediated Drug Delivery.
Gyimesi G; Hediger MA
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770817
[TBL] [Abstract][Full Text] [Related]
16. Current Advances in Studying Clinically Relevant Transporters of the Solute Carrier (SLC) Family by Connecting Computational Modeling and Data Science.
Türková A; Zdrazil B
Comput Struct Biotechnol J; 2019; 17():390-405. PubMed ID: 30976382
[TBL] [Abstract][Full Text] [Related]
17. Studying Interactions of Drugs with Cell Membrane Nutrient Transporters: New Frontiers of Proteoliposome Nanotechnology.
Scalise M; Galluccio M; Pochini L; Console L; Barile M; Giangregorio N; Tonazzi A; Indiveri C
Curr Pharm Des; 2017; 23(26):3871-3883. PubMed ID: 28625135
[TBL] [Abstract][Full Text] [Related]
18. Transcellular movement of hydroxyurea is mediated by specific solute carrier transporters.
Walker AL; Franke RM; Sparreboom A; Ware RE
Exp Hematol; 2011 Apr; 39(4):446-56. PubMed ID: 21256917
[TBL] [Abstract][Full Text] [Related]
19. Systematic identification and characterization of cynomolgus macaque solute carrier transporters.
Uno Y; Yamazaki H
Drug Metab Pharmacokinet; 2022 Apr; 43():100437. PubMed ID: 35081498
[TBL] [Abstract][Full Text] [Related]
20. High selectivity of the γ-aminobutyric acid transporter 2 (GAT-2, SLC6A13) revealed by structure-based approach.
Schlessinger A; Wittwer MB; Dahlin A; Khuri N; Bonomi M; Fan H; Giacomini KM; Sali A
J Biol Chem; 2012 Nov; 287(45):37745-56. PubMed ID: 22932902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
